Origimm
Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets.
Origimm operates in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2012.
Within the biotechnology space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2012 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.origimm.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account